New research in mice from Thomas Jefferson University has paved the way for a Phase I clinical trial and has the potential to transform vaccines against HIV and malaria.

The normal role of an gene involved in familiar Alzheimer’s, neuronal clean-up crews, and how the gut microbiome might affect osteoarthritis 

Cancer screening guidelines published last year expand eligibility for those at high risk for lung cancer, and new research shows that they also improve representation among African American patients.

A novel fibrotic disease with surprising nerve symptoms, an explanation for COVID immunity in the immunocompromised and a new approach for brain cancer

New research finds that the novel coronavirus can make the mouse brain more susceptible to a toxin that induces nerve-cell loss seen in Parkinson’s. 

The innovative and inspirational clinical trial called Cortimo, led by Thomas Jefferson University and Jefferson Health, was honored in the World Changing Ideas’ health category of Fast Company’s 2022 World Changing Ideas Awards.

How steroids affect cancer immunotherapy, the powerhouse of neurodegeneration and the molecules behind learning and memory 

Understanding how some of the world’s richest people hide their wealth in order to avoid taxation and accountability.

Thomas Jefferson University announced this week that Billy Oglesby, PhD, MBA, MSPH, FACHE has been appointed Dean of the College of Population Health. Dr. Oglesby, who joined the University in 2016, has served as interim dean since 2019.